Current Issue

Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 2

Robert Dream, Managing Director, HDR Company LLC

Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities wit...

Megan (Rabideau) Sogard, Senior Manufacturing Scheduler, Takeda (previously Manufacturing ...

Single-Use-Systems: Leachable Study Design for Single-Use Components

Katie McGohan, CMC Program Management: Advanced Therapies Lead, Regeneron (previously Scie...

NanoDSF – A Lean Technology to Test Thermal Stability of Vaccines

Marina Kirkitadze, Founding SVP of Sales, SKILLSCAPER Adjunct Professor, York University (...

Column Packing Protocol for Amsphere A3

JSR Life Sciences



Careers

Delivering Better Outcomes for Patients Starts with Creating a Workplace Where all Colleagues Can Thrive

Ahmed Elhusseiny, Roche Pharmaceuticals, Area Head, Asia Pacific

Amgen is a Company that Cares about People, I Feel Genuinely Listened to Here

Jason Rudd, Amgen, Statistical Programming Manager

Inspiring the Next Generation at Bristol Myers Squibb

Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist

A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza

Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development

At Bayer We Foster an Environment of Openness and Understanding Not Pity

Jürgen Schrapp, Bayer, Head of R&D Procurement

The Best Thing About Evotec, Without Question, Is The People

Stuart Flanagan, Evotec, Group Leader

View All Careers Articles

Headline News

Regeneron strikes Helicon peptide pact with Parabilis to build new Antibody-Helicon Conjugate class


Astrazeneca’s IMFINZI cuts early recurrences in high-risk non-muscle-invasive bladder cancer


Astellas to showcase late stage oncology portfolio at ASCO 2026 with long term follow up data


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Single-Use Chromatography – a Feasible Unit Operation?

Presented by Dr. Joachim Walter & Dr. Günter Jagschies
02nd July 2015


Risk Assessment of Extractables and Leachables in Different Phases of Development.

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Ward d’Autry, Study Director E/L & Structural Elucidation, Nelson Labs Europe
22nd April 2021


Applying Low Frequency Raman to QbD in Pharmaceutical Development

Presented by John Wasylyk, Senior Principal Scientist at Bristol-Myers Squibb Company and James Carriere, Product Line Manager for Coherent’s THz-Raman product line
26th April 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia